Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9303)
All Articles published online
|
Publishing Process of This Article
|
Apr 21, 2014 (publication date) through Nov 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Maida M, Orlando E, Cammà C, Cabibbo G. Staging systems of hepatocellular carcinoma: A review of literature. World J Gastroenterol 2014; 20(15): 4141-4150 [PMID: 24764652 DOI: 10.3748/wjg.v20.i15.4141] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i15/4141.htm |
| Number | Citing Articles |
| 1 |
Amy Leigh Collinsworth. Precision Molecular Pathology of Liver Cancer. Molecular Pathology Library 2018; : 17 doi: 10.1007/978-3-319-68082-8_2
|
| 2 |
Yan Mardian, Yoshihiko Yano, Neneng Ratnasari, Lina Choridah, Widya Wasityastuti, Nurhuda Hendra Setyawan, Yoshitake Hayashi. “Sarcopenia and intramuscular fat deposition are associated with poor survival in Indonesian patients with hepatocellular carcinoma: a retrospective study”. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1152-4
|
| 3 |
Stefania Brozzetti, Simone Bini, Chiara D’Alterio, Chiara De Lucia, Leonardo Luca Chiarella, Katia Fazzi, Michele Di Martino. Liver Disease and Surgery [Working Title]. 2019; doi: 10.5772/intechopen.86638
|
| 4 |
Jun-Cheng Wang, Jing-Yu Hou, Jian-Cong Chen, Cai-Ling Xiang, Xian-Hai Mao, Bing Yang, Qiang Li, Qing-Bo Liu, Jinbin Chen, Zhi-Wei Ye, Wei Peng, Xu-Qi Sun, Min-Shan Chen, Qun-Fang Zhou, Yao-Jun Zhang. Development and validation of prognostic nomograms for single large and huge hepatocellular carcinoma after curative resection. European Journal of Cancer 2021; 155: 85 doi: 10.1016/j.ejca.2021.07.009
|
| 5 |
Elise Verger, Pierre Drion, Geneviève Meffre, Claire Bernard, Luc Duwez, Nicolas Lepareur, Olivier Couturier, François Hindré, Roland Hustinx, Franck Lacoeuille, Hélder A. Santos. 68Ga and 188Re Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat Studies. PLOS ONE 2016; 11(10): e0164626 doi: 10.1371/journal.pone.0164626
|
| 6 |
In-Gyu Kim, Xu-Guang Hu, Hee-Jung Wang, Bong-Wan Kim, Sung Yeon Hong, Xue-Yin Shen. The 7th/8th American Joint Committee on Cancer and the Modified Union for International Cancer Control Staging System for Hepatocellular Carcinoma. Yonsei Medical Journal 2019; 60(2): 140 doi: 10.3349/ymj.2019.60.2.140
|
| 7 |
Giuseppe Cabibbo, Maria Reig, Gennaro Gadaleta-Caldarola, Giovanni Galati, Giuseppe Lombardi, GianCarlo Mazza, Luca Marzi, Carlo Saitta, Jean-Charles Nault, Rodolfo Sacco. The Calm Before the Storm: A Report from the International Liver Cancer Association Congress 2015 – Part 1. Future Oncology 2016; 12(3): 281 doi: 10.2217/fon.15.323
|
| 8 |
Masashi Utsumi, Masaru Inagaki, Koji Kitada, Naoyuki Tokunaga, Kosuke Yunoki, Yuya Sakurai, Hiroki Okabayashi, Ryosuke Hamano, Hideaki Miyasou, Yousuke Tsunemitsu, Shinya Otsuka. Predictive values of sarcopenia and systemic inflammation-based markers in advanced hepatocellular carcinoma after hepatectomy. Asian Journal of Surgery 2024; 47(7): 3039 doi: 10.1016/j.asjsur.2024.02.004
|
| 9 |
John M. Lyons, Denise M. Danos, Lauren Maniscalco, Yong Yi, Xiao-Cheng Wu, Quyen D. Chu. Trends in hepatocellular carcinoma in Louisiana, 2005–2015. Dialogues in Health 2022; 1: 100041 doi: 10.1016/j.dialog.2022.100041
|
| 10 |
Sukanta Dutta, Atanu Chandra, Saikot Ganai, Uddalak Chakraborty, Sumesh PM. Metastasis to the skull base involving the sphenoid and cavernous sinus in hepatocellular carcinoma. Journal of the Royal College of Physicians of Edinburgh 2024; 54(3): 221 doi: 10.1177/14782715241270368
|
| 11 |
Masashi Utsumi, Masaru Inagaki, Koji Kitada, Naoyuki Tokunaga, Midori Kondo, Yuya Sakurai, Kosuke Yunoki, Ryosuke Hamano, Hideaki Miyasou, Yousuke Tsunemitsu, Shinya Otsuka. Preoperative lymphocyte-to-C-reactive protein ratio predicts hepatocellular carcinoma recurrence after surgery. Annals of Surgical Treatment and Research 2022; 103(2): 72 doi: 10.4174/astr.2022.103.2.72
|
| 12 |
Wylly Ramsés García-Niño, Cecilia Zazueta. Ellagic acid: Pharmacological activities and molecular mechanisms involved in liver protection. Pharmacological Research 2015; 97: 84 doi: 10.1016/j.phrs.2015.04.008
|
| 13 |
Akshay D. Baheti, Gregor M. Dunham, Christopher R. Ingraham, Mariam Moshiri, Chandana Lall, James O. Park, David Li, Douglas S. Katz, David C. Madoff, Puneet Bhargava. Clinical implications for imaging of vascular invasion in hepatocellular carcinoma. Abdominal Radiology 2016; 41(9): 1800 doi: 10.1007/s00261-016-0763-2
|
| 14 |
Gerd Otto, Michael B Pitton, Maria Hoppe-Lotichius, Arndt Weinmann. Liver transplantation and BCLC classification: Limitations impede optimum treatment. Hepatobiliary & Pancreatic Diseases International 2021; 20(1): 6 doi: 10.1016/j.hbpd.2020.12.009
|
| 15 |
Sheng Bao, Jinyang Gu, Kai Gan, Yuan Fang, Tao Wang, Jie Lin, Zhong Zeng, Hanfei Huang. Glypican-3 and hepatocyte paraffin-1 combined with alpha-fetoprotein as a novel risk scoring model for predicting early recurrence of hepatocellular carcinoma after curative resection. European Journal of Gastroenterology & Hepatology 2021; 33(1S): e603 doi: 10.1097/MEG.0000000000002175
|
| 16 |
Edward Wolfgang Lee, Lourdes Alanis, Sung-Ki Cho, Sammy Saab. Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review. Korean Journal of Radiology 2016; 17(4): 472 doi: 10.3348/kjr.2016.17.4.472
|
| 17 |
Philip M. Hemken, Lori J. Sokoll, Xiaoqing Yang, Jianliang Dai, Debra Elliott, Susan H. Gawel, Michael Lucht, Ziding Feng, Jorge A. Marrero, Sudhir Srivastava, Daniel W. Chan, Gerard J. Davis. Validation of a novel model for the early detection of hepatocellular carcinoma. Clinical Proteomics 2019; 16(1) doi: 10.1186/s12014-018-9222-0
|
| 18 |
Yu Ling Tay, Whee Sze Ong, Sherilyn Zi Hui Liew, Anupama Roy Chowdhury, Johan Chan, Mothi Babu Ramalingam, Tanujaa Rajasekaran, Tira J. Tan, Lalit Krishna, Olive Lai, Agnes Lai Yin Chow, Simon Chen, Ravindran Kanesvaran. External validation of the first prognostic nomogram for older adults with cancer. Therapeutic Advances in Medical Oncology 2023; 15 doi: 10.1177/17588359231198433
|
| 19 |
Juntan Liu, Dandan Ding, Jiayuan Zhong, Rui Liu. Identifying the critical states and dynamic network biomarkers of cancers based on network entropy. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03445-0
|
| 20 |
Su Jong Yu. A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016. Clinical and Molecular Hepatology 2016; 22(1): 7 doi: 10.3350/cmh.2016.22.1.7
|
| 21 |
Yinjie Fan, Hang Xue, Huachuan Zheng. Systemic Therapy for Hepatocellular Carcinoma: Current Updates and Outlook. Journal of Hepatocellular Carcinoma 2022; : 233 doi: 10.2147/JHC.S358082
|
| 22 |
Li-Ju Chen, Yun-Jau Chang, Yao-Jen Chang. Survival Predictability Between the American Joint Committee on Cancer 8th Edition Staging System and the Barcelona Clinic Liver Cancer Classification in Patients with Hepatocellular Carcinoma. The Oncologist 2021; 26(3): e445 doi: 10.1002/onco.13535
|
| 23 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_188-1
|
| 24 |
Nabil Mohie Abdel-Hamid, Shimaa Ali Abass. Handbook of Cancer and Immunology. 2023; : 1 doi: 10.1007/978-3-030-80962-1_148-1
|
| 25 |
Zhiwei Zhong, Fuchun Xie, Jiajun Yin, Hua Zhao, Yuehan Zhou, Kun Guo, Rongkuan Li, Qimin Wang, Bo Tang. Development of a prognostic model for anoikis and identifies hub genes in hepatocellular carcinoma. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-41139-9
|
| 26 |
Annacarmen Petrizzo, Luigi Buonaguro. Application of the Immunoscore as prognostic tool for hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer 2016; 4(1) doi: 10.1186/s40425-016-0182-5
|
| 27 |
Xiao-Hui Wang, Bing Liao, Wen-Jie Hu, Cai-Xue Tu, Cai-Ling Xiang, Sheng-Hua Hao, Xian-Hai Mao, Xiao-Ming Qiu, Xiao-Jun Yang, Xiao Yue, Ming Kuang, Bao-Gang Peng, Shao-Qiang Li. Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus. The Oncologist 2020; 25(10): e1552 doi: 10.1634/theoncologist.2019-0766
|
| 28 |
Javier Tejeda-Maldonado, Ignacio García-Juárez, Jonathan Aguirre-Valadez, Adrián González-Aguirre, Mario Vilatobá-Chapa, Alejandra Armengol-Alonso, Francisco Escobar-Penagos, Aldo Torre, Juan Francisco Sánchez-Ávila, Diego Luis Carrillo-Pérez. Diagnosis and treatment of hepatocellular carcinoma: An update. World Journal of Hepatology 2015; 7(3): 362-376 doi: 10.4254/wjh.v7.i3.362
|
| 29 |
Yin Lai, Jin‐Chiao Lee, Hao‐Chien Hung, Chih‐Hsien Cheng, Tsung‐Han Wu, Chen‐Fang Lee, Ting‐Jung Wu, Hong‐Shiue Chou, Kun‐Ming Chan, Wei‐Chen Lee. Models to predict disease‐free survival for hepatocellular carcinoma patients with surgical resections. Journal of Surgical Oncology 2020; 122(7): 1444 doi: 10.1002/jso.26169
|
| 30 |
Giuseppe Cabibbo, Michela Antonucci, Rodolfo Sacco, Elio Sciarrino. Ultrasound-guided ablation for hepatocellular carcinoma: time for a reappraisal?. Expert Review of Anticancer Therapy 2015; 15(2): 147 doi: 10.1586/14737140.2015.1001374
|
| 31 |
Chen Jin, Chuan Li, Wei Peng, Tian-Fu Wen, Lv-Nan Yan, Bo Li, Wen-Tao Wang, Jia-Yin Yang, Ming-Qing Xu. Changes of platelet times neutrophil to lymphocyte ratio predict BCLC stage A hepatocellular carcinoma survival. Medicine 2017; 96(33): e7821 doi: 10.1097/MD.0000000000007821
|
| 32 |
Eun-Suk Cho, Jin-Young Choi. MRI Features of Hepatocellular Carcinoma Related to Biologic Behavior. Korean Journal of Radiology 2015; 16(3): 449 doi: 10.3348/kjr.2015.16.3.449
|
| 33 |
Danijel Galun, Dragan Basaric, Marinko Zuvela, Predrag Bulajic, Aleksandar Bogdanovic, Nemanja Bidzic, Miroslav Milicevic. Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols. World Journal of Hepatology 2015; 7(20): 2274-2291 doi: 10.4254/wjh.v7.i20.2274
|
| 34 |
Abdelfattah M. Attallah, Mohamed M. Omran, Ahmed A. Attallah, Mohamed A. Abdelrazek, Khaled Farid, Ibrahim El-Dosoky. Simplified HCC-ART score for highly sensitive detection of small-sized and early-stage hepatocellular carcinoma in the widely used Okuda, CLIP, and BCLC staging systems. International Journal of Clinical Oncology 2017; 22(2): 332 doi: 10.1007/s10147-016-1066-x
|
| 35 |
Annalisa Cespiati, Daniel Smith, Rosa Lombardi, Anna Ludovica Fracanzani. The Negative Impact of Sarcopenia on Hepatocellular Carcinoma Treatment Outcomes. Cancers 2024; 16(13): 2315 doi: 10.3390/cancers16132315
|
| 36 |
Masashi Utsumi, Koji Kitada, Naoyuki Tokunaga, Toru Narusaka, Ryosuke Hamano, Hideaki Miyasou, Yousuke Tsunemitsu, Shinya Otsuka, Masaru Inagaki. Preoperative Albumin-to-Globulin Ratio Predicts Prognosis in Hepatocellular Carcinoma: A Cohort Study Including Non-Hepatitis Virus-Infected Patients. Digestive Surgery 2021; 38(4): 307 doi: 10.1159/000518307
|
| 37 |
Shun-Chao Yang, Lei Liang, Ming-Da Wang, Xian-Ming Wang, Li-Hui Gu, Kong-Ying Lin, Ya-Hao Zhou, Ting-Hao Chen, Wei-Min Gu, Jie Li, Hong Wang, Zhong Chen, Chao Li, Lan-Qing Yao, Yong-Kang Diao, Li-Yang Sun, Cheng-Wu Zhang, Yong-Yi Zeng, Wan Yee Lau, Dong-Sheng Huang, Feng Shen, Tian Yang. Prospective validation of the Eastern Staging in predicting survival after surgical resection for patients with hepatocellular carcinoma: a multicenter study from China. HPB 2023; 25(1): 81 doi: 10.1016/j.hpb.2022.09.002
|
| 38 |
Wafaa Mohammed ElZefzafy, Magda Hussien, Zakia Abu Zahab Mohmmed, Nashwa Mohammed Abd Elbaky. The diagnostic value of golgi protien-73 and DICKKOPF-1 in hepatocellular carcinoma. Journal of Immunoassay and Immunochemistry 2021; 42(2): 174 doi: 10.1080/15321819.2020.1844750
|
| 39 |
Runmin Cao, Honghe Jiang, Guangpeng Liang, Weibin Zhang. SEER-based risk stratification system for patients with primary non-cirrhotic liver cancer. Journal of Cancer Research and Clinical Oncology 2023; 149(13): 12033 doi: 10.1007/s00432-023-05057-7
|
| 40 |
Ting Lin, Jingxian Gu, Kai Qu, Xing Zhang, Xiaohua Ma, Runchen Miao, Xiaohong Xiang, Yunong Fu, Wenquan Niu, Junjun She, Chang Liu. A new risk score based on twelve hepatocellular carcinoma-specific gene expression can predict the patients’ prognosis. Aging 2018; 10(9): 2480 doi: 10.18632/aging.101563
|
| 41 |
James Weiquan Li, Boon-Bee George Goh, Pik-Eu Chang, Chee-Kiat Tan. Barcelona Clinic Liver Cancer outperforms Hong Kong Liver Cancer staging of hepatocellular carcinoma in multiethnic Asians: Real-world perspective. World Journal of Gastroenterology 2017; 23(22): 4054-4063 doi: 10.3748/wjg.v23.i22.4054
|
| 42 |
Yue Xu, Xiaoqin Yao, Jinmei Li, Guoyuan Zhang, Guangcheng Luo, Qiang Wang. Establishment and application of a survival rate graph model based on biomarkers and imaging indexes after primary hepatocellular carcinoma resection. Cancer Medicine 2023; 12(12): 13329 doi: 10.1002/cam4.6031
|
| 43 |
Yong-Kang Diao, Lu Sun, Ming-Da Wang, Jun Han, Yong-Yi Zeng, Lan-Qing Yao, Xiao-Dong Sun, Chao Li, Guang-Zhao Shao, Li-Hui Gu, Han Wu, Jia-Hao Xu, Kong-Ying Lin, Zhong-Qi Fan, Wan Yee Lau, Timothy M. Pawlik, Feng Shen, Guo-Yue Lv, Tian Yang. Development and validation of nomograms to predict survival and recurrence after hepatectomy for intermediate/advanced (BCLC stage B/C) hepatocellular carcinoma. Surgery 2024; 176(1): 137 doi: 10.1016/j.surg.2024.03.028
|
| 44 |
|
| 45 |
Omar M Abdel-Rahman, Zeinab Elsayed, Omar M Abdel-Rahman. Cochrane Database of Systematic Reviews. 2014; doi: 10.1002/14651858.CD011314
|
| 46 |
Salma M. Abdelnasser, Shaymaa M. M. Yahya, Wafaa F. Mohamed, Magdy A. Gadallah, Hala M. Abu Shady, Manal G. Mahmoud, Mohsen M. S. Asker. Human apoptosis antibody array-membranes studying the apoptotic effect of marine bacterial exopolysaccharides in HepG2 cells. Journal of Cancer Research and Therapeutics 2021; 17(1): 38 doi: 10.4103/jcrt.JCRT_391_19
|
| 47 |
Thomas Couri, Anjana Pillai. Goals and targets for personalized therapy for HCC. Hepatology International 2019; 13(2): 125 doi: 10.1007/s12072-018-9919-1
|
| 48 |
Teresa Marzia Rogger, Andrea Michielan, Sandro Sferrazza, Cecilia Pravadelli, Luisa Moser, Flora Agugiaro, Giovanni Vettori, Sonia Seligmann, Elettra Merola, Marcello Maida, Francesco Antonio Ciarleglio, Alberto Brolese, Giovanni de Pretis. Gastrointestinal tract injuries after thermal ablative therapies for hepatocellular carcinoma: A case report and review of the literature. World Journal of Gastroenterology 2020; 26(35): 5375-5386 doi: 10.3748/wjg.v26.i35.5375
|
| 49 |
Akiyoshi Kinoshita, Hiroshi Onoda, Nao Fushiya, Kazuhiko Koike, Hirokazu Nishino, Hisao Tajiri. Staging systems for hepatocellular carcinoma: Current status and future perspectives. World Journal of Hepatology 2015; 7(3): 406-424 doi: 10.4254/wjh.v7.i3.406
|
| 50 |
Han Qi, Weijun Fan. Value of ablation therapy in the treatment of lung metastases. Thoracic Cancer 2018; 9(2): 199 doi: 10.1111/1759-7714.12567
|
| 51 |
Yukio Tokumitsu, Hiroaki Nagano. Hepatocellular Carcinoma. 2016; : 425 doi: 10.1007/978-3-319-34214-6_28
|
| 52 |
Giuseppe Cabibbo, Salvatore Petta, Marco Barbàra, Gabriele Missale, Roberto Virdone, Eugenio Caturelli, Fabio Piscaglia, Filomena Morisco, Antonio Colecchia, Fabio Farinati, Edoardo Giannini, Franco Trevisani, Antonio Craxì, Massimo Colombo, Calogero Cammà. A meta‐analysis of single HCV‐untreated arm of studies evaluating outcomes after curative treatments of HCV‐related hepatocellular carcinoma. Liver International 2017; 37(8): 1157 doi: 10.1111/liv.13357
|
| 53 |
Anthony W. H. Chan, Stephen L. Chan, Frankie K. F. Mo, Grace L. H. Wong, Vincent W. S. Wong, Yue-Sun Cheung, Henry L. Y. Chan, Winnie Yeo, Paul B. S. Lai, Ka-Fai To. Albumin-to-Alkaline Phosphatase Ratio: A Novel Prognostic Index for Hepatocellular Carcinoma. Disease Markers 2015; 2015: 1 doi: 10.1155/2015/564057
|
| 54 |
Peng-Sheng Yi, Ming Zhang, Ji-Tong Zhao, Ming-Qing Xu. Liver resection for intermediate hepatocellular carcinoma. World Journal of Hepatology 2016; 8(14): 607-615 doi: 10.4254/wjh.v8.i14.607
|
| 55 |
Ganesh Manudhane, Ria Mehta, Shamshersingh Chauhan, Maharudra Kumbhar. Management of Acute Coronary Syndrome With a Bleeding Intra-Tumoral Hepatocellular Carcinoma: A Case Report. Cureus 2022; doi: 10.7759/cureus.27653
|
| 56 |
Kwang Min Kim, Dong Hyun Sinn, Sin‐Ho Jung, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik. The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?. Liver International 2016; 36(10): 1490 doi: 10.1111/liv.13107
|
| 57 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3501 doi: 10.1007/978-3-319-26956-6_188
|
| 58 |
Mauro Borzio, Elena Dionigi, Angelo Rossini, Massimo Marignani, Rodolfo Sacco, Ilario De Sio, Emanuela Bertolini, Giampiero Francica, Anna Giacomin, Giancarlo Parisi, Susanna Vicari, Anna Toldi, Andrea Salmi, Sergio Boccia, Mario Mitra, Fabio Fornari. External validation of the ITA.LI.CA prognostic system for patients with hepatocellular carcinoma: A multicenter cohort study. Hepatology 2018; 67(6): 2215 doi: 10.1002/hep.29662
|
| 59 |
Guoqing Zhang, Renfeng Li, Xiaoyang Zhao, Songfeng Meng, Jianwen Ye, Longshuan Zhao. Validation of the American Joint Committee on Cancer eighth edition staging system in patients undergoing hepatectomy for hepatocellular carcinoma: a US population-based study. Journal of Surgical Research 2018; 222: 55 doi: 10.1016/j.jss.2017.09.044
|
| 60 |
R. K. Tannus, S. R. Almeida-Carvalho, C. A. Loureiro-Matos, A. Miziara-Gonzalez, A. A. Salzedas-Netto, D. Szejnfeld, G. D'Ippolito, V. Pereira-Lanzoni, I. Souza-Silva, Ferruccio Bonino. Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systems. PLOS ONE 2018; 13(4): e0194922 doi: 10.1371/journal.pone.0194922
|
| 61 |
Thayse Gardini Alvarenga, Pamela Carvalho Muniz, Hakaru Tadokoro, Ramon Andrade De Mello, Nora Manoukian Forones. International Manual of Oncology Practice. 2019; : 405 doi: 10.1007/978-3-030-16245-0_20
|
| 62 |
Bárbara Ferreira, Adrián Heredia, Jacinta Serpa. An integrative view on glucagon function and putative role in the progression of pancreatic neuroendocrine tumours (pNETs) and hepatocellular carcinomas (HCC). Molecular and Cellular Endocrinology 2023; 578: 112063 doi: 10.1016/j.mce.2023.112063
|
| 63 |
Xiao‐Hui Wang, Qing‐Bo Liu, Cai‐Ling Xiang, Xian‐Hai Mao, Bing Yang, Qiang Li, Qun‐Fang Zhou, Shao‐Qiang Li, Zhong‐Guo Zhou, Min‐Shan Chen. Multi‐institutional validation of novel models for predicting the prognosis of patients with huge hepatocellular carcinoma. International Journal of Cancer 2021; 149(1): 127 doi: 10.1002/ijc.33516
|
| 64 |
Zhi-Ming Zhang, Yu-Mei Zhang, Sheng Gao, Wei-Ping Yuan, Yin-Nong Zhao, Bang-De Xiang, Fei-Xiang Wu, Guo-Bin Wu, Jian-Yong Liu. Treatment Efficacy and Prognostic Factors for Huge HCC Based on Barcelona Clinic Liver Cancer Staging. Asian Pacific Journal of Cancer Prevention 2014; 15(20): 8823 doi: 10.7314/APJCP.2014.15.20.8823
|
| 65 |
Konstantinos Damiris, Hamza Abbad, Nikolaos Pyrsopoulos. Cellular based treatment modalities for unresectable hepatocellular carcinoma. World Journal of Clinical Oncology 2021; 12(5): 290-308 doi: 10.5306/wjco.v12.i5.290
|
| 66 |
Yan Du, Xue Han, Yi-Bo Ding, Jian-Hua Yin, Guang-Wen Cao. Prediction and prophylaxis of hepatocellular carcinoma occurrence and postoperative recurrence in chronic hepatitis B virus-infected subjects. World Journal of Gastroenterology 2016; 22(29): 6565-6572 doi: 10.3748/wjg.v22.i29.6565
|
| 67 |
CHENG-ZUO XIAO, WEI WEI, ZHI-XING GUO, SHU-HONG LI, YONG-FA ZHANG, JIA-HONG WANG, MING SHI, RONG-PING GUO. A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection. Oncology Letters 2015; 10(5): 2787 doi: 10.3892/ol.2015.3677
|
| 68 |
Berend R. Beumer, Stefan Buettner, Boris Galjart, Jeroen L.A. van Vugt, Robert A. de Man, Jan N.M. IJzermans, Bas Groot Koerkamp. Systematic review and meta-analysis of validated prognostic models for resected hepatocellular carcinoma patients. European Journal of Surgical Oncology 2022; 48(3): 492 doi: 10.1016/j.ejso.2021.09.012
|
| 69 |
Patrick Vande Lune, Ahmed K. Abdel Aal, Sergio Klimkowski, Jessica G. Zarzour, Andrew J. Gunn. Hepatocellular Carcinoma: Diagnosis, Treatment Algorithms, and Imaging Appearance after Transarterial Chemoembolization. Journal of Clinical and Translational Hepatology 2017; 6(2): 1 doi: 10.14218/JCTH.2017.00045
|
| 70 |
Khaled Mahmoud, Shady Swidan, Mohamed El-Nabarawi, Mahmoud Teaima. Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances. Journal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01309-9
|
| 71 |
Lihui Su, Tao Zhou, Zongli Zhang, Xiuguo Zhang, Xuting Zhi, Caixia Li, Qingliang Wang, Chongqi Jia, Wenna Shi, Yanqiu Yue, Yanjing Gao, Baoquan Cheng. Optimal staging system for predicting the prognosis of patients with hepatocellular carcinoma in China: a retrospective study. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2420-0
|
| 72 |
Alessandro Vitale, Fabio Farinati, Michele Finotti, Chiara Di Renzo, Giuseppina Brancaccio, Fabio Piscaglia, Giuseppe Cabibbo, Eugenio Caturelli, Gabriele Missale, Fabio Marra, Rodolfo Sacco, Edoardo Giannini, Franco Trevisani, Umberto Cillo. Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications. Cancers 2021; 13(7): 1673 doi: 10.3390/cancers13071673
|
| 73 |
Omar Abdel-Rahman, Zeinab Elsayed. External beam radiotherapy for unresectable hepatocellular carcinoma. Cochrane Database of Systematic Reviews 2017; 2017(3) doi: 10.1002/14651858.CD011314.pub2
|
| 74 |
Abhiram Natu, Anjali Singh, Sanjay Gupta. Hepatocellular carcinoma: Understanding molecular mechanisms for defining potential clinical modalities. World Journal of Hepatology 2021; 13(11): 1568-1583 doi: 10.4254/wjh.v13.i11.1568
|
| 75 |
Nitin N. Katariya, Blanca C. Lizaola-Mayo, David M. Chascsa, Emmanouil Giorgakis, Bashar A. Aqel, Adyr A. Moss, Pedro Luiz Serrano Uson Junior, Mitesh J. Borad, Amit K. Mathur. Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation. Cancers 2022; 14(9): 2056 doi: 10.3390/cancers14092056
|
| 76 |
Konstantinos Ouranos, Anthi Chatziioannou, Ioannis Goulis, Emmanouil Sinakos. Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation. World Journal of Transplantation 2022; 12(11): 331-346 doi: 10.5500/wjt.v12.i11.331
|
| 77 |
Takatsugu Matsumoto, Takayuki Shiraki, Maiko Niki, Shun Sato, Genki Tanaka, Takayuki Shimizu, Takamune Yamaguchi, Kyung-Hwa Park, Shozo Mori, Yukihiro Iso, Mitsuru Ishizuka, Keiichi Kubota, Taku Aoki. Proposal of an integrated staging system using albumin-bilirubin grade and serum alpha-fetoprotein values for predicting postoperative prognosis of recurrent hepatocellular carcinoma. European Journal of Surgical Oncology 2024; 50(6): 108356 doi: 10.1016/j.ejso.2024.108356
|
| 78 |
Tarik Demir, Sunyoung S. Lee, Ahmed O. Kaseb. Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149: 257 doi: 10.1016/bs.acr.2020.12.001
|
| 79 |
Wei-Lun Tsai, Wei-Chi Sun, Wen-Chi Chen, Chia-Ling Chiang, Huey-Shyan Lin, Huei-Lung Liang, Jin-Shiung Cheng. Hepatic arterial infusion chemotherapy vs transcatheter arterial embolization for patients with huge unresectable hepatocellular carcinoma. Medicine 2020; 99(32): e21489 doi: 10.1097/MD.0000000000021489
|
| 80 |
Zhi-Ming Zhang, Yu-Mei Zhang, Feng Yao, Ping Yi, Shang Huang, Jian-Yong Liu, Bang-De Xiang, Wei-Ping Yuan, Le-Qun Li. Analysis on Postoperative Efficacy of Radical Hepatectomy for Patients with Non-HBV/HCV Hepatocellular Carcinoma. Asian Pacific Journal of Cancer Prevention 2015; 16(8): 3479 doi: 10.7314/APJCP.2015.16.8.3479
|
| 81 |
Jingxian Gu, Xing Zhang, Zhixin Wang, Ruixia Cui, Jia Zhang, Yifan Jia, Runchen Miao, Haining Fan, Haijiu Wang, Yiming Li, Jingyao Zhang, Chang Liu, Kai Qu. Simplified nomograms based on platelet-associated models for survival prediction in Asian hepatocellular carcinoma patients after surgery. Surgical Oncology 2019; 30: 131 doi: 10.1016/j.suronc.2019.07.008
|
| 82 |
Zhan-Hong Chen, Ying-Fen Hong, Jinxiang Lin, Xing Li, Dong-Hao Wu, Jing-Yun Wen, Jie Chen, Dan-Yun Ruan, Qu Lin, Min Dong, Li Wei, Tian-Tian Wang, Ze-Xiao Lin, Xiao-Kun Ma, Xiang-Yuan Wu, Ruihua Xu. Validation and ranking of seven staging systems of hepatocellular carcinoma. Oncology Letters 2017; 14(1): 705 doi: 10.3892/ol.2017.6222
|
| 83 |
Özden ÖZDEMİR BAŞER, Nevin ORUÇ. HEPATOSELLÜLER KARSİNOMA TANILI HASTALARDA ETİYOLOJİ VE DEMOGRAFİK ÖZELLİKLER. Bozok Tıp Dergisi 2022; doi: 10.16919/bozoktip.1055425
|
| 84 |
Ariel Jaffe, Tamar H. Taddei, Edoardo G. Giannini, Ysabel C. Ilagan‐Ying, Massimo Colombo, Mario Strazzabosco. Holistic management of hepatocellular carcinoma: The hepatologist's comprehensive playbook. Liver International 2022; 42(12): 2607 doi: 10.1111/liv.15432
|
| 85 |
Jong Kwan Kim, Hyung-Don Kim, Mi-Jung Jun, Sung-Cheol Yun, Ju Hyun Shim, Han Chu Lee, Danbi Lee, Jihyun An, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee, Kang Mo Kim. Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma. Digestive Diseases and Sciences 2017; 62(10): 2923 doi: 10.1007/s10620-017-4708-6
|
| 86 |
Michele Campigotto, Mauro Giuffrè, Anna Colombo, Alessia Visintin, Alessandro Aversano, Martina Budel, Flora Masutti, Cristiana Abazia, Lory Saveria Crocé. Comparison between hepatocellular carcinoma prognostic scores: A 10-year single-center experience and brief review of the current literature. World Journal of Hepatology 2020; 12(12): 1239-1257 doi: 10.4254/wjh.v12.i12.1239
|
| 87 |
Yang Zhou, Dengliang Lei, Gangli Hu, Fang Luo. A Cell Cycle-Related 13-mRNA Signature to Predict Prognosis in Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.760190
|
| 88 |
Wan-Yuan Chen, Yong-Kang Diao, Hang-Dong Jia, Lei Liang, Tian Yang. Association Between Olfactomedin 4 and Postoperative Prognosis in Patients With Early-Stage Hepatocellular Carcinoma. Clinical and Translational Gastroenterology 2020; 11(6): e00163 doi: 10.14309/ctg.0000000000000163
|